Peripheral Neuropathy Trial, Recruiting NCT04540068 Sponsor: Eduard Verheijen Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT04540068
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a specific type of nerve pain in one side of the lower back, caused by a slipped disc or narrowing of the spine at one level.
  • People whose diagnosis has been confirmed by an MRI scan.
  • People who already have an appointment scheduled for a type of spinal injection treatment (confirm with trial site for full details of this procedure).
  • People who have access to an email account.
  • People who have signed a consent form agreeing to take part.

Who may not be able to join:

  • People who are under 18 years of age.
  • People who have serious spine disease affecting multiple levels of the spine.
  • People who have spine or back anatomy that could make the injection procedure technically difficult, such as severe curvature of the spine.
  • People who currently have an active cancer or an active infectious disease.
  • People who are taking medications that suppress the immune system.
  • People who have used steroid tablets or similar steroid medicines taken throughout the body in the past 3 months.
  • People who have already had this type of spinal injection for their current episode of lower back nerve pain.
  • People who have previously had surgery on the same part of the lower back involved in their current condition.
  • People who have circumstances that would prevent them from safely receiving the injection, such as being on blood-thinning medications that cannot be temporarily stopped, or having an allergy to steroids or local anaesthetic.
  • People who are pregnant.
  • People who have a significant language barrier that would affect participation.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Carmen LA Vleggeert-Lankamp, MD, PhD, Leiden University Medical Centre / Spaarne Gasthuis

Phone: +3171526746

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Eduard Verheijen
Registry
ClinicalTrials.gov
Start date
15 November 2020
Est. completion
1 December 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Numerical Rating Scale Leg Pain

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov